CN1615873A
(zh)
|
1999-12-24 |
2005-05-18 |
阿文蒂斯药物有限公司 |
氮杂吲哚类化合物
|
GB0115109D0
(en)
|
2001-06-21 |
2001-08-15 |
Aventis Pharma Ltd |
Chemical compounds
|
EP2335700A1
(en)
|
2001-07-25 |
2011-06-22 |
Boehringer Ingelheim (Canada) Ltd. |
Hepatitis C virus polymerase inhibitors with a heterobicylic structure
|
TWI329105B
(en)
|
2002-02-01 |
2010-08-21 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidinediamine compounds and their uses
|
GB0202679D0
(en)
*
|
2002-02-05 |
2002-03-20 |
Glaxo Group Ltd |
Novel compounds
|
TW200307542A
(en)
*
|
2002-05-30 |
2003-12-16 |
Astrazeneca Ab |
Novel compounds
|
MXPA05001688A
(es)
|
2002-08-12 |
2005-04-19 |
Sugen Inc |
3-pirrolil-piridopirazoles y 3-pirrolil-indazoles como inhibidores de cinasa novedosos.
|
SE0202463D0
(sv)
*
|
2002-08-14 |
2002-08-14 |
Astrazeneca Ab |
Novel compounds
|
US20050043212A1
(en)
*
|
2002-10-09 |
2005-02-24 |
Ford Kirschenbaum |
Differential inhibition of p38 map kinase isoforms
|
US20050288299A1
(en)
*
|
2002-10-09 |
2005-12-29 |
Mavunkel Babu J |
Azaindole derivatives as inhibitors of p38 kinase
|
WO2004032874A2
(en)
*
|
2002-10-09 |
2004-04-22 |
Scios Inc. |
AZAINDOLE DERIVATIVES AS INHIBITORS OF p38 KINASE
|
US7223785B2
(en)
|
2003-01-22 |
2007-05-29 |
Boehringer Ingelheim International Gmbh |
Viral polymerase inhibitors
|
US7098231B2
(en)
*
|
2003-01-22 |
2006-08-29 |
Boehringer Ingelheim International Gmbh |
Viral polymerase inhibitors
|
GB0305142D0
(en)
*
|
2003-03-06 |
2003-04-09 |
Eisai London Res Lab Ltd |
Synthesis
|
SE0301372D0
(sv)
*
|
2003-05-09 |
2003-05-09 |
Astrazeneca Ab |
Novel compounds
|
WO2005030121A2
(en)
*
|
2003-06-30 |
2005-04-07 |
Hif Bio, Inc. |
Compounds, compositions and methods
|
US7202363B2
(en)
|
2003-07-24 |
2007-04-10 |
Abbott Laboratories |
Thienopyridine and furopyridine kinase inhibitors
|
CN102358738A
(zh)
*
|
2003-07-30 |
2012-02-22 |
里格尔药品股份有限公司 |
2,4-嘧啶二胺化合物及其预防和治疗自体免疫疾病的用途
|
JP2007513184A
(ja)
|
2003-12-04 |
2007-05-24 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
プロテインキナーゼのインヒビターとして有用なキノキサリン
|
WO2005061519A1
(en)
*
|
2003-12-19 |
2005-07-07 |
Takeda San Diego, Inc. |
Kinase inhibitors
|
EP1718608B1
(en)
*
|
2004-02-20 |
2013-07-17 |
Boehringer Ingelheim International GmbH |
Viral polymerase inhibitors
|
PL2332940T3
(pl)
|
2004-03-30 |
2013-03-29 |
Vertex Pharma |
Azaindole użyteczne jako inhibitory JAK i innych kinaz białkowych
|
FR2868422B1
(fr)
|
2004-03-31 |
2006-07-14 |
Aventis Pharma Sa |
Nouveaux derives pyrrolo(2,3-b) pyridine, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
|
US7608627B2
(en)
*
|
2004-04-05 |
2009-10-27 |
Takeda Pharmaceutical Company Limited |
6-azaindole compound
|
US20050250829A1
(en)
*
|
2004-04-23 |
2005-11-10 |
Takeda San Diego, Inc. |
Kinase inhibitors
|
JP2008508303A
(ja)
*
|
2004-07-27 |
2008-03-21 |
エスジーエックス ファーマシューティカルズ、インコーポレイテッド |
ピロロ−ピリジンキナーゼモジュレーター
|
JP5096142B2
(ja)
|
2004-07-30 |
2012-12-12 |
メチルジーン インコーポレイテッド |
Vegfレセプターおよびhgfレセプターシグナル伝達の阻害剤
|
US7465726B2
(en)
*
|
2004-08-02 |
2008-12-16 |
Osi Pharmaceuticals, Inc. |
Substituted pyrrolo[2.3-B]pyridines
|
JP2008510734A
(ja)
*
|
2004-08-18 |
2008-04-10 |
タケダ サン ディエゴ インコーポレイテッド |
キナーゼ阻害剤
|
JP2008510792A
(ja)
*
|
2004-08-26 |
2008-04-10 |
ファイザー・インク |
タンパク質チロシンキナーゼ阻害剤としてのアミノヘテロアリール化合物
|
FR2876103B1
(fr)
*
|
2004-10-01 |
2008-02-22 |
Aventis Pharma Sa |
Nouveaux derives bis-azaindoles, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
|
US7713973B2
(en)
|
2004-10-15 |
2010-05-11 |
Takeda Pharmaceutical Company Limited |
Kinase inhibitors
|
MY179032A
(en)
*
|
2004-10-25 |
2020-10-26 |
Cancer Research Tech Ltd |
Ortho-condensed pyridine and pyrimidine derivatives (e.g.purines) as protein kinase inhibitors
|
WO2006058074A1
(en)
*
|
2004-11-22 |
2006-06-01 |
Vertex Pharmaceuticals Incorporated |
Pyrrolopyrazines and pyrazolopyrazines useful as inhibitors of protein kinases
|
WO2006063167A1
(en)
*
|
2004-12-08 |
2006-06-15 |
Smithkline Beecham Corporation |
1h-pyrrolo[2,3-b]pyridines
|
AR054416A1
(es)
|
2004-12-22 |
2007-06-27 |
Incyte Corp |
Pirrolo [2,3-b]piridin-4-il-aminas y pirrolo [2,3-b]pirimidin-4-il-aminas como inhibidores de las quinasas janus. composiciones farmaceuticas.
|
EP1831218A2
(en)
*
|
2004-12-23 |
2007-09-12 |
F.Hoffmann-La Roche Ag |
Carbamate substituted imidazo- and pyrrolo-pyridines as protein kinase inhibitors
|
ATE524467T1
(de)
*
|
2005-04-25 |
2011-09-15 |
Merck Patent Gmbh |
Neuartige aza-heterozyklen als kinase-inhibitoren
|
FR2884821B1
(fr)
*
|
2005-04-26 |
2007-07-06 |
Aventis Pharma Sa |
Pyrrolopyridines substitues, compositions les contenant, procede de fabrication et utilisation
|
ES2473341T3
(es)
|
2005-05-20 |
2014-07-04 |
Methylgene Inc |
Inhibidores de la se�alizaci�n del receptor del VEGF y del receptor del HGF
|
MX2007014619A
(es)
|
2005-05-20 |
2009-02-13 |
Vertex Pharma |
Pirrolopiridinas de utilidad como inhibidores de proteina quinasa.
|
ES2623221T3
(es)
|
2005-05-20 |
2017-07-10 |
Methylgene Inc |
Inhibidores de la señalización del receptor de VEGF y del receptor de HGF
|
CA2607901C
(en)
|
2005-06-13 |
2016-08-16 |
Rigel Pharmaceuticals, Inc. |
Methods and compositions for treating degenerative bone disorders using a syk inhibitory 2,4-pyrimidinediamine
|
PT1734251E
(pt)
*
|
2005-06-17 |
2007-03-30 |
Magneti Marelli Powertrain Spa |
Injector de combustível
|
CN102603581B
(zh)
*
|
2005-06-22 |
2015-06-24 |
普莱希科公司 |
作为蛋白质激酶抑制剂的吡咯并[2,3-b]吡啶衍生物
|
KR101142363B1
(ko)
*
|
2005-06-27 |
2012-05-21 |
주식회사유한양행 |
피롤로피리딘 유도체를 포함하는 항암제 조성물
|
JP5015154B2
(ja)
*
|
2005-08-12 |
2012-08-29 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
ウイルスポリメラーゼインヒビター
|
US8119655B2
(en)
|
2005-10-07 |
2012-02-21 |
Takeda Pharmaceutical Company Limited |
Kinase inhibitors
|
WO2007073432A2
(en)
|
2005-10-11 |
2007-06-28 |
Chemocentryx, Inc. |
Piperidine derivatives and methods of use
|
US7371862B2
(en)
|
2005-11-11 |
2008-05-13 |
Pfizer Italia S.R.L. |
Azaindolylidene derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
|
EP2514751A1
(en)
*
|
2005-11-15 |
2012-10-24 |
Vertex Pharmaceuticals, Inc. |
Azaindazoles useful as inhibitor of kinases
|
EP1963320A1
(en)
*
|
2005-12-07 |
2008-09-03 |
OSI Pharmaceuticals, Inc. |
Pyrrolopyridine kinase inhibiting compounds
|
MY162590A
(en)
|
2005-12-13 |
2017-06-30 |
Incyte Holdings Corp |
Heteroaryl substituted pyrrolo[2,3-b] pyridines and pyrrolo[2,3-b] pyrimidines as janus kinase inhibitors
|
WO2007078335A2
(en)
*
|
2005-12-21 |
2007-07-12 |
Decode Genetics, Ehf. |
Biaryl nitrogen heterocycle inhibitors of lta4h for treating inflammation
|
BRPI0706537A2
(pt)
|
2006-01-17 |
2011-03-29 |
Vertex Pharma |
azaindóis úteis como inibidores de janus cinases
|
CN101466676B
(zh)
*
|
2006-04-12 |
2012-07-18 |
默沙东公司 |
吡啶基酰胺类t-型钙通道拮抗剂
|
HUE026820T2
(en)
*
|
2006-05-09 |
2016-07-28 |
Novaremed Ltd |
The use of Syk tyrosine kinase inhibitors for the treatment of cell proliferative disorders
|
CA2858520A1
(en)
*
|
2006-05-18 |
2007-11-29 |
Pharmacyclics Inc. |
Intracellular kinase inhibitors
|
GB0617161D0
(en)
*
|
2006-08-31 |
2006-10-11 |
Vernalis R&D Ltd |
Enzyme inhibitors
|
CL2007002617A1
(es)
*
|
2006-09-11 |
2008-05-16 |
Sanofi Aventis |
Compuestos derivados de pirrolo[2,3-b]pirazin-6-ilo; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar inflamacion de las articulaciones, artritis reumatoide, tumores, linfoma de las celulas del manto.
|
EP2223925A1
(en)
*
|
2006-10-09 |
2010-09-01 |
Takeda Pharmaceutical Company Limited |
Kinase inhibitors
|
JP2010505962A
(ja)
|
2006-10-09 |
2010-02-25 |
武田薬品工業株式会社 |
キナーゼ阻害剤
|
WO2008063888A2
(en)
*
|
2006-11-22 |
2008-05-29 |
Plexxikon, Inc. |
Compounds modulating c-fms and/or c-kit activity and uses therefor
|
PE20081581A1
(es)
*
|
2006-12-21 |
2008-11-12 |
Plexxikon Inc |
COMPUESTOS PIRROLO[2,3-b]PIRIDINAS COMO MODULADORES DE QUINASA
|
EP2815750A1
(en)
|
2006-12-21 |
2014-12-24 |
Vertex Pharmaceuticals Incorporated |
5-cyano-4-(pyrrolo [2,3b] pyridine-3-yl)-pyrimidine derivatives useful as protein kinase inhibitors
|
US20090068110A1
(en)
*
|
2006-12-22 |
2009-03-12 |
Genentech, Inc. |
Antibodies to insulin-like growth factor receptor
|
EP2141148B1
(en)
|
2007-03-29 |
2013-07-03 |
Daiichi Sankyo Company, Limited |
Indole derivative having cpla2 inhibitory activity, use of the same and method for producing the same
|
EP3495369B1
(en)
|
2007-06-13 |
2021-10-27 |
Incyte Holdings Corporation |
Use of salts of the janus kinase inhibitor (r)-3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h- pyrazol-1-yl)-3- cyclopentylpropanenitrile
|
US20100190777A1
(en)
|
2007-07-17 |
2010-07-29 |
Plexxikon Inc. |
Compounds and methods for kinase modulation, and indications therefor
|
WO2009046448A1
(en)
|
2007-10-04 |
2009-04-09 |
Intellikine, Inc. |
Chemical entities and therapeutic uses thereof
|
EP2212291B1
(en)
|
2007-10-24 |
2014-06-04 |
Merck Sharp & Dohme Corp. |
Heterocycle phenyl amide t-type calcium channel antagonists
|
WO2009054983A1
(en)
*
|
2007-10-24 |
2009-04-30 |
Merck & Co., Inc. |
Heterocycle amide t-type calcium channel antagonists
|
WO2009106445A1
(en)
*
|
2008-02-25 |
2009-09-03 |
F. Hoffmann-La Roche Ag |
Pyrrolopyrazine kinase inhibitors
|
CN101952296B
(zh)
|
2008-02-25 |
2013-08-21 |
霍夫曼-拉罗奇有限公司 |
吡咯并吡嗪激酶抑制剂
|
EP2245033B1
(en)
|
2008-02-25 |
2011-08-31 |
F. Hoffmann-La Roche AG |
Pyrrolopyrazine kinase inhibitors
|
ATE522536T1
(de)
|
2008-02-25 |
2011-09-15 |
Hoffmann La Roche |
Pyrrolopyrazin-kinasehemmer
|
KR101261514B1
(ko)
|
2008-02-25 |
2013-05-07 |
에프. 호프만-라 로슈 아게 |
피롤로피라진 키나아제 저해제
|
EP2332536A1
(en)
|
2008-03-05 |
2011-06-15 |
MethylGene Inc. |
Inhibitors of protein tyrosine kinase activity
|
US8993580B2
(en)
|
2008-03-14 |
2015-03-31 |
Intellikine Llc |
Benzothiazole kinase inhibitors and methods of use
|
US8637542B2
(en)
|
2008-03-14 |
2014-01-28 |
Intellikine, Inc. |
Kinase inhibitors and methods of use
|
CA2723961C
(en)
|
2008-05-21 |
2017-03-21 |
Ariad Pharmaceuticals, Inc. |
Phosphorous derivatives as kinase inhibitors
|
US9273077B2
(en)
|
2008-05-21 |
2016-03-01 |
Ariad Pharmaceuticals, Inc. |
Phosphorus derivatives as kinase inhibitors
|
WO2009152083A1
(en)
*
|
2008-06-10 |
2009-12-17 |
Plexxikon, Inc. |
5h-pyrr0l0 [2,3-b] pyrazine derivatives for kinase modulation, and indications therefor
|
WO2010006086A2
(en)
*
|
2008-07-08 |
2010-01-14 |
Intellikine, Inc. |
Kinase inhibitors and methods of use
|
US8476431B2
(en)
|
2008-11-03 |
2013-07-02 |
Itellikine LLC |
Benzoxazole kinase inhibitors and methods of use
|
US8846664B2
(en)
|
2008-11-12 |
2014-09-30 |
Ariad Pharmaceuticals, Inc. |
Pyrazinopyrazines and derivatives as kinase inhibitors
|
ES2524966T3
(es)
|
2008-12-05 |
2014-12-16 |
Abbvie Bahamas Ltd. |
Derivados de tieno[3,2-c]piridina como inhibidores de quinasas para uso en el tratamiento del cáncer
|
SG171956A1
(en)
*
|
2008-12-05 |
2011-07-28 |
Hoffmann La Roche |
Pyrrolopyrazinyl urea kinase inhibitors
|
EP2381777A4
(en)
|
2008-12-12 |
2012-08-08 |
Ariad Pharma Inc |
AZAINDOL DERIVATIVES AS KINASEHEMMER
|
KR101724293B1
(ko)
|
2009-02-25 |
2017-04-07 |
다케다 야쿠힌 고교 가부시키가이샤 |
피롤 화합물의 제조 방법
|
US20110112101A1
(en)
*
|
2009-03-05 |
2011-05-12 |
Sanofi-Aventis |
Treatment for ocular-related disorders
|
CR20170089A
(es)
*
|
2009-04-03 |
2017-07-17 |
Plexxikon Inc |
Composiciones del acido propano-1--sulfonico {3-[5-(4-cloro-fenil)-1h-pirrolo [2,3-b] piridina-3-carbonil] -2,4-difluoro-fenil}-amida y el uso de las mismas
|
WO2010135411A2
(en)
*
|
2009-05-19 |
2010-11-25 |
The Regents Of The University Of Colorado |
Aurora-a copy number and sensitivity to inhibitors
|
US20100316639A1
(en)
|
2009-06-16 |
2010-12-16 |
Genentech, Inc. |
Biomarkers for igf-1r inhibitor therapy
|
RS57869B1
(sr)
|
2009-06-17 |
2018-12-31 |
Vertex Pharma |
Inhibitori replikacije virusa gripa
|
US8329724B2
(en)
|
2009-08-03 |
2012-12-11 |
Hoffmann-La Roche Inc. |
Process for the manufacture of pharmaceutically active compounds
|
FR2949467B1
(fr)
|
2009-09-03 |
2011-11-25 |
Sanofi Aventis |
Nouveaux derives de 5,6,7,8-tetrahydroindolizine inhibiteurs d'hsp90, compositions les contenant et utilisation
|
NZ599866A
(en)
|
2009-11-06 |
2014-09-26 |
Plexxikon Inc |
Compounds and methods for kinase modulation, and indications therefor
|
EP2338890A1
(en)
|
2009-12-22 |
2011-06-29 |
Bayer CropScience AG |
4,7-Diazaindole derivatives and their use as fungicides
|
ME02186B
(me)
|
2009-12-23 |
2016-02-20 |
Takeda Pharmaceuticals Co |
Fuzionisani heteroaromatski pirolidinoni kao syk inhibitori
|
WO2011094288A1
(en)
*
|
2010-01-27 |
2011-08-04 |
Vertex Pharmaceuticals Incorporated |
Pyrazolopyrazine kinase inhibitors
|
WO2011109932A1
(en)
*
|
2010-03-09 |
2011-09-15 |
F.Hoffmann-La Roche Ag |
Novel process for the manufacture of 5-halogenated-7-azaindoles
|
SI3354652T1
(sl)
|
2010-03-10 |
2020-08-31 |
Incyte Holdings Corporation |
Derivati piperidin-4-il azetidina kot inhibitorji JAK1
|
US8518945B2
(en)
|
2010-03-22 |
2013-08-27 |
Hoffmann-La Roche Inc. |
Pyrrolopyrazine kinase inhibitors
|
US8481541B2
(en)
*
|
2010-03-22 |
2013-07-09 |
Hoffmann-La Roche Inc. |
Pyrrolopyrazine kinase inhibitors
|
BR112012029437A2
(pt)
*
|
2010-05-20 |
2017-03-07 |
F Hoffmann - La Roche Ag |
derivados de pirrolo[2,3-b]pirazina-7-carboxamida e seu uso como inibidores de jak e syk
|
MX2012013194A
(es)
|
2010-05-20 |
2013-01-22 |
Hoffmann La Roche |
Derivados pirrolopirazinas como inhibidores de cinasas tirocina-cinasa del baso (syk) y cinasa de janus (jak).
|
SG10201910912TA
(en)
|
2010-05-21 |
2020-01-30 |
Incyte Corp |
Topical Formulation for a JAK Inhibitor
|
CA2800176C
(en)
*
|
2010-05-24 |
2018-08-28 |
University Of Rochester |
Bicyclic heteroaryl kinase inhibitors and methods of use
|
US8993634B2
(en)
|
2010-06-02 |
2015-03-31 |
The Trustees Of The University Of Pennsylvania |
Methods and use of compounds that bind to Her2/neu receptor complex
|
US9265739B2
(en)
|
2010-06-02 |
2016-02-23 |
The Trustees Of The University Of Pennsylvania |
Methods and use of compounds that bind to HER2/neu receptor complex
|
US8846928B2
(en)
*
|
2010-11-01 |
2014-09-30 |
Portola Pharmaceuticals, Inc. |
Benzamides and nicotinamides as Syk modulators
|
BR112013012502A2
(pt)
|
2010-11-19 |
2019-03-06 |
Incyte Corporation |
pirrolopiridina ciclobutil substituída e derivados de pirrolopirimidina derivativos como inibidores de jak
|
KR20140014110A
(ko)
|
2010-12-16 |
2014-02-05 |
버텍스 파마슈티칼스 인코포레이티드 |
인플루엔자 바이러스 복제의 억제제
|
WO2012088266A2
(en)
|
2010-12-22 |
2012-06-28 |
Incyte Corporation |
Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
|
MA34948B1
(fr)
|
2011-02-07 |
2014-03-01 |
Plexxikon Inc |
Composes et procedes de modulation de kinase, et leurs indications
|
TWI558702B
(zh)
|
2011-02-21 |
2016-11-21 |
普雷辛肯公司 |
醫藥活性物質的固態形式
|
TWI592411B
(zh)
|
2011-02-23 |
2017-07-21 |
英特爾立秦有限責任公司 |
激酶抑制劑之組合及其用途
|
CN103501612B
(zh)
|
2011-05-04 |
2017-03-29 |
阿里亚德医药股份有限公司 |
抑制表皮生长因子受体导致的癌症中细胞增殖的化合物
|
US9120785B2
(en)
|
2011-05-10 |
2015-09-01 |
Merck Sharp & Dohme Corp. |
Pyridyl aminopyridines as Syk inhibitors
|
WO2012154518A1
(en)
|
2011-05-10 |
2012-11-15 |
Merck Sharp & Dohme Corp. |
Bipyridylaminopyridines as syk inhibitors
|
CA2834604A1
(en)
|
2011-05-10 |
2012-11-15 |
Merck Sharp & Dohme Corp. |
Aminopyrimidines as syk inhibitors
|
MY165963A
(en)
|
2011-06-20 |
2018-05-18 |
Incyte Holdings Corp |
Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as jak inhibitors
|
EP2723739B1
(en)
|
2011-06-22 |
2016-08-24 |
Takeda Pharmaceutical Company Limited |
Substituted 6-aza-isoindolin-1-one derivatives
|
CA2839937C
(en)
|
2011-07-05 |
2020-11-03 |
Vertex Pharmaceuticals Incorporated |
Processes and intermediates for producing azaindoles
|
WO2013012909A1
(en)
|
2011-07-20 |
2013-01-24 |
Abbott Laboratories |
Kinase inhibitor with improved aqueous solubility
|
UA118010C2
(uk)
|
2011-08-01 |
2018-11-12 |
Вертекс Фармасьютікалз Інкорпорейтед |
Інгібітори реплікації вірусів грипу
|
DE102011111400A1
(de)
|
2011-08-23 |
2013-02-28 |
Merck Patent Gmbh |
Bicyclische heteroaromatische Verbindungen
|
AU2012308570B2
(en)
|
2011-09-14 |
2016-11-10 |
Samumed, Llc |
Indazole-3-carboxamides and their use as Wnt/b-catenin signaling pathway inhibitors
|
WO2013052394A1
(en)
|
2011-10-05 |
2013-04-11 |
Merck Sharp & Dohme Corp. |
2-pyridyl carboxamide-containing spleen tyrosine kinase (syk) inhibitors
|
EP2763975B1
(en)
|
2011-10-05 |
2016-04-06 |
Merck Sharp & Dohme Corp. |
3-pyridyl carboxamide-containing spleen tyrosine kinase (syk) inhibitors
|
WO2013052391A1
(en)
|
2011-10-05 |
2013-04-11 |
Merck Sharp & Dohme Corp. |
PHENYL CARBOXAMIDE-CONTAINING SPLEEN TYROSINE KINASE (Syk) INHIBITORS
|
PH12017500997A1
(en)
|
2012-04-04 |
2018-02-19 |
Samumed Llc |
Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof
|
JP6182593B2
(ja)
|
2012-04-20 |
2017-08-16 |
アドヴィーナス セラピューティクス リミテッド |
置換ヘテロ二環化合物、組成物及び医薬並びにそれらの用途
|
WO2013169401A1
(en)
|
2012-05-05 |
2013-11-14 |
Ariad Pharmaceuticals, Inc. |
Compounds for inhibiting cell proliferation in egfr-driven cancers
|
US9150570B2
(en)
|
2012-05-31 |
2015-10-06 |
Plexxikon Inc. |
Synthesis of heterocyclic compounds
|
PT3176170T
(pt)
|
2012-06-13 |
2019-02-05 |
Incyte Holdings Corp |
Compostos tricíclicos substituídos como inibidores de fgfr
|
WO2013192128A1
(en)
|
2012-06-20 |
2013-12-27 |
Merck Sharp & Dohme Corp. |
Imidazolyl analogs as syk inhibitors
|
EP2863914B1
(en)
|
2012-06-20 |
2018-10-03 |
Merck Sharp & Dohme Corp. |
Pyrazolyl derivatives as syk inhibitors
|
EP2863916B1
(en)
|
2012-06-22 |
2018-07-18 |
Merck Sharp & Dohme Corp. |
Substituted pyridine spleen tyrosine kinase (syk) inhibitors
|
EP2863915B1
(en)
|
2012-06-22 |
2017-12-06 |
Merck Sharp & Dohme Corp. |
SUBSTITUTED DIAZINE AND TRIAZINE SPLEEN TYROSINE KINASE (Syk) INHIBITORS
|
CN102718694B
(zh)
*
|
2012-06-27 |
2014-04-02 |
上海大学 |
3-氰基取代吲哚化合物及其合成方法
|
US9388185B2
(en)
|
2012-08-10 |
2016-07-12 |
Incyte Holdings Corporation |
Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors
|
EP2884982B1
(en)
|
2012-08-20 |
2017-09-20 |
Merck Sharp & Dohme Corp. |
SUBSTITUTED PHENYL SPLEEN TYROSINE KINASE (Syk) INHIBITORS
|
SG11201503695XA
(en)
|
2012-11-15 |
2015-06-29 |
Incyte Corp |
Sustained-release dosage forms of ruxolitinib
|
EP2738172A1
(en)
*
|
2012-11-28 |
2014-06-04 |
Almirall, S.A. |
New bicyclic compounds as crac channel modulators
|
US9266892B2
(en)
|
2012-12-19 |
2016-02-23 |
Incyte Holdings Corporation |
Fused pyrazoles as FGFR inhibitors
|
CN105120862A
(zh)
|
2013-01-08 |
2015-12-02 |
萨穆梅德有限公司 |
Wnt信号途径的3-(苯并咪唑-2-基)-吲唑抑制剂及其治疗应用
|
US9468681B2
(en)
|
2013-03-01 |
2016-10-18 |
California Institute Of Technology |
Targeted nanoparticles
|
EA030705B1
(ru)
|
2013-03-06 |
2018-09-28 |
Инсайт Холдингс Корпорейшн |
Способы и промежуточные соединения при получении ингибитора jak
|
MY191366A
(en)
|
2013-03-13 |
2022-06-20 |
Forma Therapeutics Inc |
Novel compounds and compositions for inhibition of fasn
|
WO2014151444A1
(en)
*
|
2013-03-14 |
2014-09-25 |
Abbvie Inc. |
Pyrrolo[2,3-b]pyridine cdk9 kinase inhibitors
|
AU2014231567A1
(en)
*
|
2013-03-14 |
2015-10-01 |
Abbvie Inc. |
Pyrrolo[2,3-b]pyridine CDK9 kinase inhibitors
|
US9611283B1
(en)
|
2013-04-10 |
2017-04-04 |
Ariad Pharmaceuticals, Inc. |
Methods for inhibiting cell proliferation in ALK-driven cancers
|
PE20152033A1
(es)
|
2013-04-19 |
2016-01-21 |
Incyte Holdings Corp |
Heterociclos bicicliclos como inhibidores de fgfr
|
ES2792549T3
(es)
|
2013-08-07 |
2020-11-11 |
Incyte Corp |
Formas de dosificación de liberación sostenida para un inhibidor de JAK1
|
JPWO2015029447A1
(ja)
*
|
2013-08-30 |
2017-03-02 |
興和株式会社 |
光学活性カルビノール化合物の製造方法
|
SI3068782T1
(sl)
|
2013-11-13 |
2018-10-30 |
Vertex Pharmaceuticals Incorporated |
Postopki za pripravo inhibitorjev v replikacije virusov gripe
|
JP6615755B2
(ja)
|
2013-11-13 |
2019-12-04 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
インフルエンザウイルスの複製の阻害剤
|
WO2016040184A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
WO2016040181A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
WO2016040193A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridine and therapeutic uses thereof
|
WO2016040190A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridine and therapeutic uses thereof
|
WO2016040180A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(1h-benzo[d]imidazol-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
WO2016040185A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
2-(1h-indazol-3-yl)-3h-imidazo[4,5-b]pyridine and therapeutic uses thereof
|
US10851105B2
(en)
|
2014-10-22 |
2020-12-01 |
Incyte Corporation |
Bicyclic heterocycles as FGFR4 inhibitors
|
SG10201909060SA
(en)
|
2014-12-11 |
2019-11-28 |
Beta Pharma Inc |
Substituted 2-anilinopyrimidine derivatives as egfr modulators
|
EP3617205B1
(en)
|
2015-02-20 |
2021-08-04 |
Incyte Corporation |
Bicyclic heterocycles as fgfr inhibitors
|
US9580423B2
(en)
|
2015-02-20 |
2017-02-28 |
Incyte Corporation |
Bicyclic heterocycles as FGFR4 inhibitors
|
MA41551A
(fr)
|
2015-02-20 |
2017-12-26 |
Incyte Corp |
Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4
|
JP6857617B2
(ja)
|
2015-05-13 |
2021-04-14 |
バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated |
インフルエンザウイルスの複製の阻害剤
|
EP3294717B1
(en)
|
2015-05-13 |
2020-07-29 |
Vertex Pharmaceuticals Inc. |
Methods of preparing inhibitors of influenza viruses replication
|
ES2882255T3
(es)
|
2015-07-01 |
2021-12-01 |
California Inst Of Techn |
Sistemas de administración basados en polímeros de ácido múcico catiónicos
|
US10226448B2
(en)
|
2015-08-03 |
2019-03-12 |
Samumed, Llc |
3-(1H-pyrrolo[3,2-C]pyridin-2-yl)-1H-pyrazolo[3,4-B]pyridines and therapeutic uses thereof
|
US10226453B2
(en)
|
2015-08-03 |
2019-03-12 |
Samumed, Llc |
3-(1H-indol-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
WO2017024026A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc |
3-(1h-indol-2-yl)-1h-pyrazolo[3,4-c]pyridines and therapeutic uses thereof
|
WO2017024015A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
WO2017024021A1
(en)
*
|
2015-08-03 |
2017-02-09 |
Samumed, Llc |
3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-indazoles and therapeutic uses thereof
|
WO2017023980A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridines and therapeutic uses thereof
|
US10188634B2
(en)
|
2015-08-03 |
2019-01-29 |
Samumed, Llc |
3-(3H-imidazo[4,5-C]pyridin-2-yl)-1 H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
US10206908B2
(en)
|
2015-08-03 |
2019-02-19 |
Samumed, Llc |
3-(1H-pyrrolo[3,2-C]pyridin-2-YL)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof
|
WO2017024004A1
(en)
*
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
US10392383B2
(en)
|
2015-08-03 |
2019-08-27 |
Samumed, Llc |
3-(1H-benzo[d]imidazol-2-yl)-1H-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
US10285983B2
(en)
|
2015-08-03 |
2019-05-14 |
Samumed, Llc |
3-(1H-pyrrolo[2,3-B]pyridin-2-yl)-1H-pyrazolo[3,4-B] pyridines and therapeutic uses thereof
|
US10463651B2
(en)
|
2015-08-03 |
2019-11-05 |
Samumed, Llc |
3-(1H-pyrrolo[3,2-C]pyridin-2-YL)-1H-indazoles and therapeutic uses thereof
|
US10604512B2
(en)
|
2015-08-03 |
2020-03-31 |
Samumed, Llc |
3-(1H-indol-2-yl)-1H-indazoles and therapeutic uses thereof
|
WO2017023972A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
US10383861B2
(en)
|
2015-08-03 |
2019-08-20 |
Sammumed, LLC |
3-(1H-pyrrolo[2,3-C]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof
|
US10519169B2
(en)
|
2015-08-03 |
2019-12-31 |
Samumed, Llc |
3-(1H-pyrrolo[2,3-C]pyridin-2-yl)-1 H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
US10231956B2
(en)
|
2015-08-03 |
2019-03-19 |
Samumed, Llc |
3-(1H-pyrrolo[3,2-C]pyridin-2-YL)-1 H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
WO2017064217A1
(en)
*
|
2015-10-13 |
2017-04-20 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Sibiriline derivatives for use for preventing and/or treating disorders associated with cellular necroptosis
|
CA3004297A1
(en)
|
2015-11-06 |
2017-05-11 |
Samumed, Llc |
2-(1h-indazol-3-yl)-3h-imidazo[4,5-c]pyridines and their anti-inflammatory uses thereof
|
SG11201804711RA
(en)
*
|
2015-12-07 |
2018-07-30 |
Plexxikon Inc |
Compounds and methods for kinase modulation, and indications therefor
|
AR107030A1
(es)
*
|
2015-12-09 |
2018-03-14 |
Padlock Therapeutics Inc |
Inhibidores aza-bencimidazol de pad4
|
US20190060286A1
(en)
|
2016-02-29 |
2019-02-28 |
University Of Florida Research Foundation, Incorpo |
Chemotherapeutic Methods
|
CN106008306A
(zh)
*
|
2016-06-28 |
2016-10-12 |
山东大学 |
取代吲哚类衍生物及其制备方法与应用
|
JP2019535672A
(ja)
|
2016-10-21 |
2019-12-12 |
サミュメッド リミテッド ライアビリティ カンパニー |
インダゾール−3−カルボキサミドの使用方法およびwnt/β−カテニンシグナル伝達経路阻害剤としてのそれらの使用
|
MA46696A
(fr)
|
2016-11-07 |
2019-09-11 |
Samumed Llc |
Formulations injectables à dose unique prêtes à l'emploi
|
AR111960A1
(es)
|
2017-05-26 |
2019-09-04 |
Incyte Corp |
Formas cristalinas de un inhibidor de fgfr y procesos para su preparación
|
WO2018226846A1
(en)
|
2017-06-07 |
2018-12-13 |
Plexxikon Inc. |
Compounds and methods for kinase modulation
|
US10596161B2
(en)
|
2017-12-08 |
2020-03-24 |
Incyte Corporation |
Low dose combination therapy for treatment of myeloproliferative neoplasms
|
PL3746429T3
(pl)
|
2018-01-30 |
2022-06-20 |
Incyte Corporation |
Procesy do otrzymywania (1-(3-fluoro-2-(trifluorometylo)izonikotynoilo)piperydyn-4-onu)
|
WO2019191684A1
(en)
|
2018-03-30 |
2019-10-03 |
Incyte Corporation |
Treatment of hidradenitis suppurativa using jak inhibitors
|
CN108358894B
(zh)
*
|
2018-04-26 |
2021-05-07 |
四川大学 |
一种抑制组蛋白乙酰转移酶的化合物及其制备方法与应用
|
CN112867716A
(zh)
|
2018-05-04 |
2021-05-28 |
因赛特公司 |
Fgfr抑制剂的固体形式和其制备方法
|
CA3099116A1
(en)
|
2018-05-04 |
2019-11-07 |
Incyte Corporation |
Salts of an fgfr inhibitor
|
TWI767148B
(zh)
|
2018-10-10 |
2022-06-11 |
美商弗瑪治療公司 |
抑制脂肪酸合成酶(fasn)
|
US10793554B2
(en)
|
2018-10-29 |
2020-10-06 |
Forma Therapeutics, Inc. |
Solid forms of 4-(2-fluoro-4-(1-methyl-1H-benzo[d]imidazol-5-yl)benzoyl)piperazin-1-yl)(1-hydroxycyclopropyl)methanone
|
CN113874015A
(zh)
|
2018-12-21 |
2021-12-31 |
细胞基因公司 |
Ripk2的噻吩并吡啶抑制剂
|
MX2021007925A
(es)
|
2018-12-31 |
2021-10-26 |
Biomea Fusion Llc |
Inhibidores irreversibles de la interaccion menina-mll.
|
EP3906029A4
(en)
|
2018-12-31 |
2022-09-21 |
Biomea Fusion, LLC |
INHIBITORS OF MENIN-MLL INTERACTION
|
WO2020160151A1
(en)
*
|
2019-01-31 |
2020-08-06 |
Kyorin Pharmaceutical Co., Ltd. |
15-pgdh inhibitors
|
WO2020185532A1
(en)
|
2019-03-08 |
2020-09-17 |
Incyte Corporation |
Methods of treating cancer with an fgfr inhibitor
|
CN111171001B
(zh)
*
|
2019-05-16 |
2022-04-29 |
百济神州(苏州)生物科技有限公司 |
一种parp抑制剂中间体的结晶方法
|
WO2021007269A1
(en)
|
2019-07-09 |
2021-01-14 |
Incyte Corporation |
Bicyclic heterocycles as fgfr inhibitors
|
JOP20220083A1
(ar)
|
2019-10-14 |
2023-01-30 |
Incyte Corp |
حلقات غير متجانسة ثنائية الحلقة كمثبطات لـ fgfr
|
US11566028B2
(en)
|
2019-10-16 |
2023-01-31 |
Incyte Corporation |
Bicyclic heterocycles as FGFR inhibitors
|
CA3163875A1
(en)
|
2019-12-04 |
2021-06-10 |
Incyte Corporation |
Tricyclic heterocycles as fgfr inhibitors
|
CA3162010A1
(en)
|
2019-12-04 |
2021-06-10 |
Incyte Corporation |
Derivatives of an fgfr inhibitor
|
US20230116201A1
(en)
*
|
2020-01-30 |
2023-04-13 |
Anima Biotech Inc. |
Collagen 1 translation inhibitors and methods of use thereof
|
US11833155B2
(en)
|
2020-06-03 |
2023-12-05 |
Incyte Corporation |
Combination therapy for treatment of myeloproliferative neoplasms
|
US11939331B2
(en)
|
2021-06-09 |
2024-03-26 |
Incyte Corporation |
Tricyclic heterocycles as FGFR inhibitors
|
WO2024026500A2
(en)
*
|
2022-07-28 |
2024-02-01 |
University Of Maryland, Baltimore |
Inhibitors of pde11a4 and methods of using same
|